Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.08, Yahoo Finance reports.
Anebulo Pharmaceuticals Price Performance
ANEB stock opened at $2.05 on Friday. Anebulo Pharmaceuticals has a 1 year low of $1.62 and a 1 year high of $3.61. The company has a market cap of $53.16 million, a P/E ratio of -5.54 and a beta of -1.01. The stock’s fifty day moving average price is $2.05 and its 200-day moving average price is $2.35.
Anebulo Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Anebulo Pharmaceuticals
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is Put Option Volume?
- MarketBeat Week in Review – 9/23 – 9/27
- With Risk Tolerance, One Size Does Not Fit All
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Anebulo Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anebulo Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.